Therefore, although we focused on the regulation of p53 by MDM2 in this manuscript, a mechanism already known and described for some time, we introduced a new fundamental node represented by the kinase p90RSK, which makes this mechanism the basis of a possible new therapeutic target for many types of cancer. This evidence concerns the gene MDM2 and cancer.